TipRanks
Recce Pharmaceuticals Ltd. (AU:RCE)
ASX:RCE
Australian Market
Want to see AU:RCE full AI Analyst Report?

Recce Pharmaceuticals Ltd. (RCE) Income Statement

22 Followers

Recce Pharmaceuticals Ltd. Income Statement

Last quarter (Q4 2026), Recce Pharmaceuticals Ltd.'s total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Recce Pharmaceuticals Ltd.'s net income was AU$1.60M. See Recce Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 0.00AU$ 7.51MAU$ 5.03MAU$ 4.37MAU$ 3.08M
Gross Profit
AU$ -356.40KAU$ -2.94MAU$ -2.19MAU$ 4.15MAU$ 2.90M
Operating Expenses
AU$ 22.81MAU$ 19.94MAU$ 21.68MAU$ 17.11MAU$ 13.96M
Depreciation and Amortization
AU$ 356.40KAU$ 356.16KAU$ 366.77KAU$ 217.16KAU$ 187.67K
EBITDA
AU$ -22.81MAU$ -20.05MAU$ -21.35MAU$ -16.99MAU$ -13.87M
Operating Income
AU$ -23.16MAU$ -22.88MAU$ -22.05MAU$ -17.33MAU$ -14.15M
Other Income/Expenses
AU$ -677.39KAU$ 1.45MAU$ -516.49KAU$ -63.06KAU$ 79.07K
Pretax Income
AU$ -23.84MAU$ -21.43MAU$ -22.57MAU$ -17.39MAU$ -14.07M
Net Income
AU$ -14.96MAU$ -21.43MAU$ -17.66MAU$ -13.08MAU$ -10.99M
Per Share Metrics
Basic EPS
AU$ -0.05AU$ -0.09AU$ -0.10AU$ -0.07AU$ -0.06
Diluted EPS
AU$ -0.05AU$ -0.09AU$ -0.10AU$ -0.07AU$ -0.06
Weighted Average Shares Outstanding
289.15M 236.98M 177.10M 175.71M 175.87M
Weighted Average Shares Outstanding (Diluted)
289.15M 236.98M 177.10M 175.71M 175.87M
Currency in AUD

Recce Pharmaceuticals Ltd. Earnings and Revenue History